BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

525 related articles for article (PubMed ID: 34945111)

  • 1. Immunomonitoring of Monocyte and Neutrophil Function in Critically Ill Patients: From Sepsis and/or Trauma to COVID-19.
    Udovicic I; Stanojevic I; Djordjevic D; Zeba S; Rondovic G; Abazovic T; Lazic S; Vojvodic D; To K; Abazovic D; Khan W; Surbatovic M
    J Clin Med; 2021 Dec; 10(24):. PubMed ID: 34945111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal assessment of IFN-I activity and immune profile in critically ill COVID-19 patients with acute respiratory distress syndrome.
    Venet F; Cour M; Rimmelé T; Viel S; Yonis H; Coudereau R; Amaz C; Abraham P; Monard C; Casalegno JS; Brengel-Pesce K; Lukaszewicz AC; Argaud L; Monneret G;
    Crit Care; 2021 Apr; 25(1):140. PubMed ID: 33845874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ratio of neutrophil to lymphocyte counts--rapid and simple parameter of systemic inflammation and stress in critically ill.
    Zahorec R
    Bratisl Lek Listy; 2001; 102(1):5-14. PubMed ID: 11723675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The prognostic value of serum procalcitonin on severity of illness in non-sepsis critically ill patients].
    Ma J; Wang S; Chen D; Duan J; Li C; Li G
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2016 Aug; 28(8):688-93. PubMed ID: 27434557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of neutrophil chemotaxis activity as an immunologic biomarker to predict mortality in critically-ill patients with severe sepsis.
    Srisawat N; Kulvichit W; Tungsanga S; Peerapornratana S; Vorasitchai S; Tangkanakul C; Lumlertgul N; Komaenthammasophon C; Praditpornsilpa K; Tungsanga K; Eiam-Ong S
    J Crit Care; 2020 Apr; 56():215-221. PubMed ID: 31982695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The REAnimation Low Immune Status Markers (REALISM) project: a protocol for broad characterisation and follow-up of injury-induced immunosuppression in intensive care unit (ICU) critically ill patients.
    Rol ML; Venet F; Rimmele T; Moucadel V; Cortez P; Quemeneur L; Gardiner D; Griffiths A; Pachot A; Textoris J; Monneret G;
    BMJ Open; 2017 Jun; 7(6):e015734. PubMed ID: 28637738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoinflammatory response in critically ill patients: severe sepsis and/or trauma.
    Surbatovic M; Veljovic M; Jevdjic J; Popovic N; Djordjevic D; Radakovic S
    Mediators Inflamm; 2013; 2013():362793. PubMed ID: 24371374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frontline Science: Defects in immune function in patients with sepsis are associated with PD-1 or PD-L1 expression and can be restored by antibodies targeting PD-1 or PD-L1.
    Patera AC; Drewry AM; Chang K; Beiter ER; Osborne D; Hotchkiss RS
    J Leukoc Biol; 2016 Dec; 100(6):1239-1254. PubMed ID: 27671246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal stem cells derived from perinatal tissues for treatment of critically ill COVID-19-induced ARDS patients: a case series.
    Hashemian SR; Aliannejad R; Zarrabi M; Soleimani M; Vosough M; Hosseini SE; Hossieni H; Keshel SH; Naderpour Z; Hajizadeh-Saffar E; Shajareh E; Jamaati H; Soufi-Zomorrod M; Khavandgar N; Alemi H; Karimi A; Pak N; Rouzbahani NH; Nouri M; Sorouri M; Kashani L; Madani H; Aghdami N; Vasei M; Baharvand H
    Stem Cell Res Ther; 2021 Jan; 12(1):91. PubMed ID: 33514427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Red blood cell transfusion results in adhesion of neutrophils in human endotoxemia and in critically ill patients with sepsis.
    van Hezel ME; Boshuizen M; Peters AL; Straat M; Vlaar AP; Spoelstra-de Man AME; Tanck MWT; Tool ATJ; Beuger BM; Kuijpers TW; Juffermans NP; van Bruggen R
    Transfusion; 2020 Feb; 60(2):294-302. PubMed ID: 31804732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monocyte HLA-DR Assessment by a Novel Point-of-Care Device Is Feasible for Early Identification of ICU Patients With Complicated Courses-A
    Tamulyte S; Kopplin J; Brenner T; Weigand MA; Uhle F
    Front Immunol; 2019; 10():432. PubMed ID: 30915080
    [No Abstract]   [Full Text] [Related]  

  • 12. Leucocyte activation markers in clinical practice.
    Viedma Contreras JA
    Clin Chem Lab Med; 1999 Jun; 37(6):607-22. PubMed ID: 10475068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum resistin levels in critically ill patients are associated with inflammation, organ dysfunction and metabolism and may predict survival of non-septic patients.
    Koch A; Gressner OA; Sanson E; Tacke F; Trautwein C
    Crit Care; 2009; 13(3):R95. PubMed ID: 19545363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemadsorption.
    Cutuli SL; Grieco DL; De Pascale G; Antonelli M
    Curr Opin Anaesthesiol; 2021 Apr; 34(2):113-118. PubMed ID: 33470661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid Mediators in Critically Ill Patients: A Step Towards Precision Medicine.
    Cioccari L; Luethi N; Masoodi M
    Front Immunol; 2020; 11():599853. PubMed ID: 33324417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal correlation of biomarkers of cardiac injury, inflammation, and coagulation to outcome in hospitalized COVID-19 patients.
    Li C; Jiang J; Wang F; Zhou N; Veronese G; Moslehi JJ; Ammirati E; Wang DW
    J Mol Cell Cardiol; 2020 Oct; 147():74-87. PubMed ID: 32827510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating soluble urokinase plasminogen activator receptor is stably elevated during the first week of treatment in the intensive care unit and predicts mortality in critically ill patients.
    Koch A; Voigt S; Kruschinski C; Sanson E; Dückers H; Horn A; Yagmur E; Zimmermann H; Trautwein C; Tacke F
    Crit Care; 2011; 15(1):R63. PubMed ID: 21324198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysregulated plasma lipid mediator profiles in critically ill COVID-19 patients.
    Palmas F; Clarke J; Colas RA; Gomez EA; Keogh A; Boylan M; McEvoy N; McElvaney OJ; McElvaney O; Alalqam R; McElvaney NG; Curley GF; Dalli J
    PLoS One; 2021; 16(8):e0256226. PubMed ID: 34437568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune Modulation in Critically Ill Septic Patients.
    Cutuli SL; Carelli S; Grieco DL; De Pascale G
    Medicina (Kaunas); 2021 May; 57(6):. PubMed ID: 34072649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in Biomarkers in Critical Ill Polytrauma Patients.
    Papurica M; Rogobete AF; Sandesc D; Dumache R; Cradigati CA; Sarandan M; Nartita R; Popovici SE; Bedreag OH
    Clin Lab; 2016; 62(6):977-86. PubMed ID: 27468558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.